About Aureus Sciences
Aureus Sciences is a Healthcare company based in Paris (France) founded in 2000, and was acquired by Elsevier in January 2013. It operates as a knowledge Management Systems for drug discovery research. It operates in the Healthcare and Technology sectors. Its focus areas include Enterprise Applications, Data as a Service, Industries and Healthcare Data. Its competitors include NantHealth, BioAge Labs, Perthera, Ontoforce and Genedata and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
Aureus Science has developed a Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. The companys products are AurQUEST, a query management software that allows the extraction of information relevant to drug discovery; AurPROFILER that searches across various knowledge bases to identify target, cell, or drugcompound profiles; DDI Predict, which predicts drug-drug interactions between proprietary drugs and a panel of drugs; and AurPASS that predicts biological activity profiles for selected compounds. Its platform contains various databases, including ADME database, GPCR database, GPS database, ion channel database, kinase database, nuclear receptors database, and protease database. As of January 8, 2013, Aureus Sciences SA was acquired by Elsevier B.V
- Headquarters Paris, France
- Stage Acquired
- SectorsHealthcareTechnology
- Website aureus-sciences.com
- Social LinkedIn X
- Acquired by Elsevier (Jan 2013)
Investors in Aureus Sciences
Aureus Sciences has secured backing from 1 investor. Prominent investors backing the company include Elsevier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Information solutions for science, health, and technology professionals are provided. | 1880 | elsevier.com | Amsterdam, Netherlands |
Investor details for Aureus Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Aureus Sciences
2 dated milestones of Aureus Sciences across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Aureus Sciences is founded.
- Exit Acquired by Elsevier.
Competitors of Aureus Sciences
Aureus Sciences has 9 listed competitors in our database, 7 of them funded. They include NantHealth, BioAge Labs, Perthera, Ontoforce and Genedata, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanthealth.com | 2007 | El Segundo, United States | $607.58M | 380 | Bioinformatics platforms are provided for cancer treatment identification. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| perthera.com | 2012 | Mclean, United States | $17.02M | 13 | Molecular cancer profiling is conducted via genomics and proteomics. | |
| ontoforce.com | 2011 | Ghent, Belgium | $9.13M | 31 | Semantic search platform is provided for pharmaceutical and biotech research. | |
| genedata.com | 1997 | Basel, Switzerland | – | 66 | Software solutions are developed for drug discovery and life sciences. | |
| dandelionhealth.ai | 2020 | New York, United States | $15.89M | – | AI-powered real-world data platform is provided for clinical development. | |
| cyclicarx.com | 2010 | Toronto, Canada | $21.06M | – | Online AI-interfacedpredictive analytics platform for drug discovery and testing | |
| airfinity.com | 2015 | London, United Kingdom | – | 57 | Predictive data analysis software is developed for researchers. | |
| syntekabio.com | 2009 | Sunnyvale, United States | $11.12M | – | Life science-specific software and services are provided by Syntekabio. |
Detailed competitors of Aureus Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Aureus Sciences
Websites that share an audience with Aureus Sciences (aureus-sciences.com).
Websites whose visitors overlap most with Aureus Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| lifemapsc.com | 100% | 11.7K | #1,996,272 | View details |
Top companies in Life Sciences Platforms & Tools
10 companies that operate in the same segment as Aureus Sciences (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | 1,111 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aureus Sciences
Aureus Sciences was founded in 2000.
Aureus Sciences is headquartered in Paris, France.
Aureus Science has developed a Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. The companys products are AurQUEST, a query management software that allows the extraction of information relevant to drug discovery; AurPROFILER that searches across various knowledge bases to identify target, cell, or drugcompound profiles; DDI Predict, which predicts drug-drug interactions between proprietary drugs and a panel of drugs; and AurPASS that predicts biological activity profiles for selected compounds. Its platform contains various databases, including ADME database, GPCR database, GPS database, ion channel database, kinase database, nuclear receptors database, and protease database. As of January 8, 2013, Aureus Sciences SA was acquired by Elsevier B.V.
Aureus Sciences's top competitors include NantHealth, BioAge Labs and Genedata.
Aureus Sciences has 1 investor. Key investors include Elsevier.
Yes. Aureus Sciences was acquired by Elsevier in January 2013.